STAR THERAPEUTICS PRESENTS INTERIM DATA FROM PHASE 1/2 MULTIDOSE STUDY OF VGA039 IN VON WILLEBRAND DISEASE, DEMONSTRATING SUBSTANTIAL BLEED REDUCTIONS IN ALL PATIENTS, AT ASH ANNUAL MEETING VGA039 is a once monthly, subcutaneously self-administered therapy for the...
Sunbird Bio Presents New Clinical Data Supporting the Accuracy of its Blood-Based Alpha-Synuclein Assay for Parkinson’s Disease Detection– The sunbird αSyn™ assay accurately classified Parkinson’s disease-positive blood samples with 81% accuracy through the direct...
RevSpring to Acquire Kyruus Health, Creating a Connected Care Journey from Search to Final Payment Unified platform will support whole-person engagement while simplifying operations and improving financial outcomes for healthcare organizations NASHVILLE, Tenn., and...
Edgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies – New open label data in Becker demonstrated sustained disease stabilization up to three years, reinforcing prior clinical findings – – Ongoing pivotal...
Kyruus Health and Healthgrades Partner to Improve Patient Access and Digital Presence for Healthcare Providers BOSTON, Mass., Oct. 1, 2025 — Kyruus Health, the leading care access platform, today announced a strategic partnership with Healthgrades, the premier...
Electra Therapeutics Announces $183 Million Series C Financing to Advance First-in-Class SIRP-Targeted Therapies for Immune Disorders and Cancer Proceeds will fund a global pivotal trial of lead product candidate, ELA026, as a frontline treatment for secondary...
Recent Comments